Literature DB >> 33906973

Select hyperactivating NLRP3 ligands enhance the TH1- and TH17-inducing potential of human type 2 conventional dendritic cells.

Lukas Hatscher1, Christian H K Lehmann1, Ariawan Purbojo2, Constantin Onderka3, Chunguang Liang4, Arndt Hartmann5, Robert Cesnjevar2, Heiko Bruns6, Olaf Gross7,8,9, Falk Nimmerjahn10, Ivana Ivanović-Burmazović3,11, Meik Kunz4, Lukas Heger1, Diana Dudziak12,10,13,14,15.   

Abstract

The detection of microorganisms and danger signals by pattern recognition receptors on dendritic cells (DCs) and the consequent formation of inflammasomes are pivotal for initiating protective immune responses. Although the activation of inflammasomes leading to secretion of the cytokine IL-1β is typically accompanied by pyroptosis (an inflammatory form of lytic programmed cell death), some cells can survive and exist in a state of hyperactivation. Here, we found that the conventional type 2 DC (cDC2) subset is the major human DC subset that is transcriptionally and functionally poised for inflammasome formation and response without pyroptosis. When cDC2 were stimulated with ligands that relatively weakly activated the inflammasome, the cells did not enter pyroptosis but instead secreted IL-12 family cytokines and IL-1β. These cytokines induced prominent T helper type 1 (TH1) and TH17 responses that were superior to those seen in response to Toll-like receptor (TLR) stimulation alone or to stronger, classical inflammasome ligands. These findings not only define the human cDC2 subpopulation as a prime target for the treatment of inflammasome-dependent inflammatory diseases but may also inform new approaches for adjuvant and vaccine development.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33906973     DOI: 10.1126/scisignal.abe1757

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  8 in total

Review 1.  Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers.

Authors:  Alicia Cristina Peña-Romero; Esteban Orenes-Piñero
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639

2.  Adenovirus-α-Defensin Complexes Induce NLRP3-Associated Maturation of Human Phagocytes via Toll-Like Receptor 4 Engagement.

Authors:  Karsten Eichholz; Tuan Hiep Tran; Coraline Chéneau; Thi Thu Phuong Tran; Océane Paris; Martine Pugniere; Eric J Kremer
Journal:  J Virol       Date:  2022-01-26       Impact factor: 6.549

Review 3.  Innate immune detection of lipid oxidation as a threat assessment strategy.

Authors:  Dania Zhivaki; Jonathan C Kagan
Journal:  Nat Rev Immunol       Date:  2021-09-21       Impact factor: 108.555

4.  Toxoplasma gondii Rhoptry Protein 7 (ROP7) Interacts with NLRP3 and Promotes Inflammasome Hyperactivation in THP-1-Derived Macrophages.

Authors:  Lijun Zhu; Wanjun Qi; Guang Yang; Yurong Yang; Yuwen Wang; Lulu Zheng; Yongfeng Fu; Xunjia Cheng
Journal:  Cells       Date:  2022-05-12       Impact factor: 7.666

Review 5.  Inflammasome Contribution to the Activation of Th1, Th2, and Th17 Immune Responses.

Authors:  Ekaterina Martynova; Albert Rizvanov; Richard A Urbanowicz; Svetlana Khaiboullina
Journal:  Front Microbiol       Date:  2022-03-17       Impact factor: 5.640

6.  Incorporation of Toll-Like Receptor Ligands and Inflammasome Stimuli in GM3 Liposomes to Induce Dendritic Cell Maturation and T Cell Responses.

Authors:  Maarten K Nijen Twilhaar; Lucas Czentner; Rianne G Bouma; Katarzyna Olesek; Joanna Grabowska; Aru Zeling Wang; Alsya J Affandi; Saskia C Belt; Hakan Kalay; Cornelus F van Nostrum; Yvette van Kooyk; Gert Storm; Joke M M den Haan
Journal:  Front Immunol       Date:  2022-02-18       Impact factor: 7.561

7.  Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccination.

Authors:  Sebastian J Theobald; Alexander Simonis; Julie M Mudler; Ulrike Göbel; Richard Acton; Viktoria Kohlhas; Marie-Christine Albert; Anna-Maria Hellmann; Jakob J Malin; Sandra Winter; Michael Hallek; Henning Walczak; Phuong-Hien Nguyen; Manuel Koch; Jan Rybniker
Journal:  EMBO Mol Med       Date:  2022-07-04       Impact factor: 14.260

Review 8.  Immunostimulatory Polymers as Adjuvants, Immunotherapies, and Delivery Systems.

Authors:  Adam M Weiss; Samir Hossainy; Stuart J Rowan; Jeffrey A Hubbell; Aaron P Esser-Kahn
Journal:  Macromolecules       Date:  2022-08-04       Impact factor: 6.057

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.